Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Comparative Molecular Pathology Unit (CMPU)

The Comparative Molecular Pathology initiative is intended to spearhead opportunities for bridging basic and clinical research efforts by more precisely optimizing the development, characterization and utilization of models of human disease. The initiative will include both applied research and collaborations aimed at developing new reagents, methods, and technologies in preclinical diagnostic medicine; thus enhancing capabilities to integrate molecular and systemic aspects of disease mechanisms. Designing and employing state of the art medical and pathology investigative tools to the study of animal models will help promote translational phenotype comprehension, and therefore improve model predictability for human cancer diseases.

The comparative molecular pathology unit has 4 main spheres of activity focused on translational research within the NCI Center for Cancer Research:

Noninvasive diagnostic and molecular medical imaging
Developing molecular diagnostics for research
Research investigation and animal model validation
Training in comparative and molecular pathology